Watchlist Price Alert

Fresh Tracks Therapeutics... (FRTX)

NASDAQ: FRTX · Real-Time Price · USD

0.94

0.00 (0.00%)

At close: Feb 28, 2025, 12:19 PM

0.00% (1D)

Bid	n/a
Market Cap	5.59M
Revenue (ttm)	8.01M
Net Income (ttm)	-5.63M
EPS (ttm)	-1.06
PE Ratio (ttm)	-0.8820754716981132
Forward PE	n/a
Analyst	n/a

Ask	n/a
Volume	2,162
Avg. Volume (20D)	2,666
Open	0.94
Previous Close	0.94
Day's Range	0.94 - 0.94
52-Week Range	0.03 - 1.03
Beta	1.17

About FRTX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol FRTX

Website n/a

Full Company Profile

News

1 year ago · investorplace.com

7 F-Rated Biotech Stocks You Shouldn't Touch With a 10-Foot Pole

Investing in biotech stocks can be challenging. The rewards can be great when your company hits on a popular drug, treatment or product.

2 years ago · investorplace.com

Why Is Fresh Tracks Therapeutics (FRTX) Stock Up 92% Today?

Fresh Tracks Therapeutics (NASDAQ: FRTX ) stock is heading higher on Wednesday after announcing positive results from a Phase 1 clinical trial. That clinical trial covers the use of FRTX-02 to restore...

2 years ago · pennystocks.com

Best Penny Stocks To Buy? 4 To Watch In January 2023

4 Biotech Penny Stocks To Watch, January 2023 The post Best Penny Stocks To Buy? 4 To Watch In January 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

2 years ago · seekingalpha.com

Fresh Tracks Therapeutics, Inc. (FRTX) Q3 2022 Earnings Call Transcript

Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTX ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Garth Russell - LifeSci Advisors Robert Brown - CEO Monica Luchi - Chi...

2 years ago · zacks.com

Fresh Tracks Therapeutics (FRTX) Reports Q3 Loss, Tops Revenue Estimates

Fresh Tracks Therapeutics (FRTX) delivered earnings and revenue surprises of -9.52% and 56.77%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

2 years ago · seekingalpha.com

Brickell Biotech, Inc. (BBI) CEO Robert Brown on Q2 2022 Results - Earnings Call Transcript

Brickell Biotech, Inc. (NASDAQ:BBI ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Garth Russell - IR, LifeSci Advisors Robert Brown - Chief Executive Officer Monica...

2 years ago · pulse2.com

Brickell Biotech (BBI) Stock: 1-For-45 Reverse Split Announced

Brickell Biotech, Inc. (Nasdaq: BBI) announced a 1-for-45 reverse split. These are the details.

2 years ago · investorplace.com

Brickell Biotech (BBI) Stock Gains 50% Ahead of Meeting to Prevent Delisting

Delistings are commonplace in this bear market, however investors in Brickell Biotech and BBI stock are cheering some news today. The post Brickell Biotech (BBI) Stock Gains 50% Ahead of Meeting to Pr...